Terms ending in 2036
Every in-force patent on CMPD Licensing, LLC's record whose computed term ends in 2036, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,898,455 | Urea Cream Formulations In force · High confidence | CMPD Licensing LLC | In force | High confidence | |
| US 9,999,604 | Compounded Solutions of Diclofenac and Lidocaine and Methods In force · High confidence | CMPD Licensing LLC | In force | High confidence | |
| US 10,525,025 | Compounded Compositions and Methods for Treating Pain In force · High confidence | CMPD Licensing, LLC | In force | High confidence | |
| US 10,610,503 | Compounded Solutions of Diclofenac and Lidocaine and Methods In force · High confidence | CMPD Licensing LLC | In force | High confidence | |
| US 10,966,946 | Compounded Compositions and Methods for Treating Pain In force · High confidence | CMPD Licensing, LLC | In force | High confidence | |
| US 11,278,508 | Compounded Compositions and Methods for Treating Pain In force · High confidence | CMPD Licensing, LLC | In force | High confidence | |
| US 11,737,975 | Compounded Compositions and Methods for Treating Pain In force · High confidence | CMPD Licensing, LLC | In force | High confidence | |
| US 11,826,330 | Compounded Compositions and Methods for Treating Pain In force · High confidence | CMPD Licensing, LLC | In force | High confidence | |
| US 11,986,448 | Compounded Compositions and Methods for Treating Pain In force · High confidence | CMPD Licensing, LLC | In force | High confidence | |
| US 12,370,160 | Compounded Compositions and Methods for Treating Pain In force · Low confidence | CMPD Licensing, LLC | In force | Low confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.